AlphaFold predicted structure
MPL · P40238

Mean pLDDT
72.7/ 100
Confident
635 residues
Confidence breakdown
- Very high(≥ 90)32%
- Confident(70–90)35%
- Low(50–70)11%
- Very low(< 50)23%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
MPL proto-oncogene, thrombopoietin receptor
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
BIALLELIC, autosomal or pseudoautosomalCytopenia - NOT Fanconi anaemia
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
BIALLELIC, autosomal or pseudoautosomalInherited bleeding disorders
BIALLELIC, autosomal or pseudoautosomalThrombocythaemia
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
BIALLELIC, autosomal or pseudoautosomalcongenital amegakaryocytic thrombocytopenia 1
thrombocythemia 2
congenital amegakaryocytic thrombocytopenia
Thrombocytopenia
primary myelofibrosis
essential thrombocythemia
autoimmune thrombocytopenic purpura
aplastic anemia
hemorrhage
chronic hepatitis C virus infection
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Thrombopoietin receptor
Receptor for thrombopoietin that regulates hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Upon activation by THPO, induces rapid tyrosine phosphorylation and activation of JAK2, providing docking sites for many signaling proteins such as STAT5, SHIP/INPP5D, GRB2, SOS1 and PI3K (PubMed:15899890, PubMed:37633268). In turn, These signaling cascades lead to the proliferation, survival, and differentiation of megakaryocytes, ultimately leading to increased platelet production
Curated MONDO disease pages that list MPL among their top associated genes.
MPL · P40238

Mean pLDDT
72.7/ 100
Confident
635 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0